Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and the Lung Availability of CHF 5993 in Healthy Volunteers
Clinical trial NCT02743013 · COMPLETED
Trial details
- NCT number
- NCT02743013
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2016-07-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.